KD investerar i Alzheimer-bolag

Företagsinkubatorn blir delägare i Biochromix

By Anna Sundström

April 18, 2011 12:00 AM

- Investeringen förstärker vårt engagemang i kampen mot Alzheimers sjukdom, säger Torbjørn Bjerke, vd på Karolinska development som nu äger åtta procent av Uppsalabaserade Biochromix.

Kapitaltillskottet kommer genom

en nyemission som riktats till Karolinska development.

Biochromix är ett

företag som utvecklar metoder för in vitro-diagnostik. Bolaget utvecklar också läkemedel mot neurodegenerativa sjukdomar.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.